The growing role of remote trials in pharma; why fentanyl test strips are still illegal in many states

Taking stock of the drug industry, from the lab to the medicine chest ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by       STAT+: Even before Covid-19, remote trials saved money. Will pharma now rely on them more than ever? By Ed Silverman Adobe Even before Covid-19, remote trials saved money. The pandemic may accelerate the use of certain techniques. Read More STAT+: What disclosure? Clinical trials run in Canada fail to take basic steps toward transparency By Ed Silverman Molly Ferguson for STAT “It’s a pretty damning finding,” said Matthew Herder, who heads the Health Law Institute at Dalhousie University. Read More Fentanyl test strips could help save lives. In many states, they're still illegal By Lev Facher Mark Lennihan/AP Fentanyl test strips are classified as drug paraphernalia in Texas, Florida, and elsewhere — making it a crime to possess or distribute them. Read More Sponsor content by InCrowd STAT E-Book: What's next for mental health care’s technology transformation Technology is changing the mental health care landscape. New entrants poised to disrupt the industry face challenges, including skepticism from the traditional health care system. And there are still looming questions about how to best deliver care. Our latest e-book lays out the potential for technology to transform how mental health care is delivered and the myriad ways it is already making an impact. Download now. Illumina's $8 billion limbo, a new treatment for ALS, & Emirati biotech funding By Damian Garde and Allison DeAngelis and Adam Feuerstein Our colleague Matthew Herper joins us to discuss how Illumina, the biggest company in genomic sequencing, got into an $8 billion predicament. Read More A new report brings telehealth fraud risk into focus By Mohana Ravindranath Adobe A new watchdog report offers early evidence on how often providers are billing for virtual care in a potentially fraudulent way. Read More Thursday, September 8, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser